6-(4-Chlorophenyl)-3,4-dihydrothieno[3,2-d]-pyrimidin-4-one, 1g

(R)-1-(4-Bromophenyl)-2,2,2-trifluoroethanamine, 95.0%, 250mg

1-(fluoromethyl)-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 1g

Objetivo de estaño 99,999% dia. 25,4 mm x espesor 6,35 mm 1 ud.

S-(7-Oxo-7-((4-phenylthiazol-2-yl)amino)heptyl) 2-methylpropanethioate, 95.0%, 10mg

tert-Butyl 4-(3-ethoxy-3-oxopropyl)piperidine-1-carboxylate, 95.0%, 5g

2-Amino-4-methyl-5-acetylthiazole, 97.0%, 5g

(2-bromophenyl)[(tert-butoxycarbonyl)amino]acetic acid, 95.0%, 250mg

(S)-3-((S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one, 95.0%, 5g

N-Acetyl-l-phenylalanine methyl ester, 95.0%, 25g

2-(2-Chlorophenyl)-5,7-dihydroxy-8-((3S,4R)-3-hydroxy-1-methylpiperidin-4-yl)-4H-chromen-4-one hydrochloride, 98%, 25mg

3-(difluoromethoxy)cyclobutane-1-carboxylic acid, 100mg

5-[(3,4-dimethylphenoxy)methyl]-4-ethyl-4H-1,2,4-triazole-3-thiol, 95.0%, 5g